Harmony Biosciences Holdings (HRMY) Other Working Capital Changes (2019 - 2026)
Harmony Biosciences Holdings (HRMY) reported Other Working Capital Changes of $2000.0 for Q4 2023, up 200.0% sequentially from -$2000.0 in Q3 2023.
Harmony Biosciences Holdings (HRMY) Other Working Capital Changes (2019 - 2026) Analysis & Trends
Harmony Biosciences Holdings (HRMY) has 5 years of Other Working Capital Changes data on file, last reported at $2000.0 in Q4 2023.
- For the quarter ending Q4 2023, Other Working Capital Changes changed N/A year-over-year to $2000.0; the trailing twelve-month figure through Dec 2023 stood at $1000.0 (up 100.66% YoY), and the FY2023 full-year result was -$1000.0, up 99.34% from the prior year.
- Other Working Capital Changes climbed to $2000.0 in Q4 2023, from -$2000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $4.0 million in Q3 2023 to a low of -$24.8 million in Q4 2025.
- A 5-year average of -$1.1 million and a median of $997000.0 in 2022 frame the typical range for Other Working Capital Changes.
- Across the five-year window, Other Working Capital Changes surged 282.76% in 2021 and plunged 375.0% in 2022, its largest moves.
- Tracing HRMY's Other Working Capital Changes over 5 years: stood at -$142000.0 in 2019, then soared by 189.44% to $127000.0 in 2020, then tumbled by 227.56% to -$162000.0 in 2021, then jumped by 100.62% to $1000.0 in 2022, then surged by 100.0% to $2000.0 in 2023.
- Business Quant data shows HRMY's Other Working Capital Changes at $2000.0 in Q4 2023, -$2000.0 in Q3 2023, and $1000.0 in Q3 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Harmony Biosciences Holdings | 2.09 Bn | 1.57 Bn | 170.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.00 Mn |
| Mar 31, 2026 | 3.00 Mn |
| Mar 31, 2026 | 3.00 Mn |
| Dec 31, 2025 | -24.85 Mn |
| Dec 31, 2025 | -24.85 Mn |
| Dec 31, 2025 | -24.85 Mn |
| Sep 30, 2025 | -12.53 Mn |
| Sep 30, 2025 | -12.53 Mn |
| Sep 30, 2025 | -12.53 Mn |
| Jun 30, 2025 | 3.59 Mn |
| Jun 30, 2025 | 3.59 Mn |
| Jun 30, 2025 | 3.59 Mn |
| Mar 31, 2025 | 2.00 Mn |
| Mar 31, 2025 | 2.00 Mn |
| Mar 31, 2025 | 2.00 Mn |
| Dec 31, 2024 | -1.84 Mn |
| Dec 31, 2024 | -1.84 Mn |
| Dec 31, 2024 | -1.84 Mn |
| Sep 30, 2024 | 847,000.00 |
| Sep 30, 2024 | 847,000.00 |